12-14424813-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018179.5(ATF7IP):āc.898G>Cā(p.Val300Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018179.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATF7IP | NM_018179.5 | c.898G>C | p.Val300Leu | missense_variant | 2/15 | ENST00000261168.9 | NP_060649.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATF7IP | ENST00000261168.9 | c.898G>C | p.Val300Leu | missense_variant | 2/15 | 5 | NM_018179.5 | ENSP00000261168 | P5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251310Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135818
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461842Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727212
GnomAD4 genome AF: 0.000164 AC: 25AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.898G>C (p.V300L) alteration is located in exon 2 (coding exon 1) of the ATF7IP gene. This alteration results from a G to C substitution at nucleotide position 898, causing the valine (V) at amino acid position 300 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at